Zobrazeno 1 - 10
of 222
pro vyhledávání: '"Francisco A. Arabia"'
Autor:
Octavio E. Pajaro, Dawn E. Jaroszewski, Robert L. Scott, Anantharam V. Kalya, Henry D. Tazelaar, Francisco A. Arabia
Publikováno v:
Journal of Transplantation, Vol 2011 (2011)
Antibody-mediated rejection (AMR) (humoral rejection) of cardiac allografts remains difficult to diagnose and treat. Interest in AMR of cardiac allografts has increased over the last decade as it has become apparent that untreated humoral rejection t
Externí odkaz:
https://doaj.org/article/b33e4c1e7dca4c0daf2778c9bd0bc5fb
Autor:
Alexander M. Bernhardt, Hannah Copeland, Anita Deswal, Jason Gluck, Michael M. Givertz, Arthur Reshad Garan, Shelley Hall, Awori Hayanga, Ivan Knezevic, Federico Pappalardo, Joyce Wald, Cristiano Amarelli, William L. Baker, David Baran, Daniel Dilling, Airlie Hogan, Anna L. Meyer, Ivan Netuka, Minoru Ono, Gustavo Parrilla, Duc Thin Pham, Scott Silvestry, Christy Smith, Koji Takeda, Sunu S. Thomas, Esther Vorovich, Jo Ellen Rodgers, Nana Aburjania, Jean M. Connors, Jasmin S. Hanke, Elrina Joubert-Huebner, Gal Levy, Ann E. Woolley, David L.S. Morales, Amanda Vest, Francisco A. Arabia, Michael Carrier, Christopher T. Salerno, Benedikt Schrage, Savitri Fedson, Larry A. Allen, Cynthia J. Bither, Shannon Dunlay, Paola Morejon, Kay Kendall, Michael Kiernan, Sean Pinney, Stephan Schueler, Peter Macdonald, Diyar Saeed, Evgenij Potapov, Tien M.H. Ng
Publikováno v:
The Journal of Heart and Lung Transplantation. 42:e1-e64
Autor:
Francisco A. Arabia
Publikováno v:
Cardiology in Review. 28:275-282
The total artificial heart (TAH) is a device that replaces the failing ventricles. There have been numerous TAHs designed over the last few decades, but the one with the largest patient experience is the SynCardia TAH-t. The 50-mL and 70-mL sizes hav
Autor:
James K. Kirklin, Francis D. Pagani, Daniel J. Goldstein, Ranjit John, Joseph G. Rogers, Pavan Atluri, Francisco A. Arabia, Anson Cheung, William Holman, Charles Hoopes, Valuvan Jeevanandam, Ulrich P. Jorde, Carmelo A. Milano, Nader Moazami, Yoshifumi Naka, Ivan Netuka, Salpy V. Pamboukian, Sean Pinney, Craig H. Selzman, Scott Silverstry, Mark Slaughter, John Stulak, Jeff Teuteberg, Juliane Vierecke, Stephan Schueler, David A. D'Alessandro
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:187-219
Autor:
C. Runyan, Konrad Schlick, Patrick D. Lyden, Jaime Moriguchi, Oksana Volod, Matthew M. Padrick, Shlee S. Song, Francisco A. Arabia, Oana M. Dumitrascu, Kara Melmed, Mani Nezhad, Brenda Rinsky
Publikováno v:
J Neuroimaging
Background and purpose Mechanical circulatory support (MCS) devices are commonly used in heart failure patients. These devices carry risk for presumably embolic and additionally hemorrhagic stroke. Alterations in blood flow play a key role in stroke
Publikováno v:
Surgical technology international. 39
The SynCardia Total Artificial Heart (TAH, SynCardia Systems, Tucson, AZ) is the only biventricular cardiac replacement approved for bridge to transplantation by the U.S. Food and Drug Administration (FDA) and which carries the European Union CE mark
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 159:e227-e229
Autor:
Francisco A. Arabia, Lawrence S.C. Czer, Devin Koehl, Danny Ramzy, Ryan S. Cantor, Richard G. Smith, Vigneshwar Kasirajan, Jon A. Kobashigawa, Fardad Esmailian, Igor D. Gregoric, J. Chung, Jaime Moriguchi, James K. Kirklin
Publikováno v:
The Journal of Heart and Lung Transplantation. 37:1304-1312
BACKGROUND We sought to better understand the patient population who receive a temporary total artificial heart (TAH) as bridge to transplant or as bridge to decision by evaluating data from the Interagency Registry for Mechanically Assisted Circulat
Publikováno v:
Annals of cardiothoracic surgery. 9(2)
Heart failure is a complex, growing problem with significant morbidity and mortality. Though heart transplantation remains the gold standard treatment for end-stage heart failure, there remains a national shortage of donor hearts. Mechanical circulat
Publikováno v:
Annals of cardiothoracic surgery. 9(2)